Artificial pancreas better for glycaemic control than conven
In patients with diabetes, hospitalization can complicate the achievement of recommended glycemic targets. The present study investigated whether a closed-loop system (artificial pancreas) could also improve glycemic control in patients with type 2 diabetes who were receiving noncritical care.

The researchers assigned 136 adults with type 2 diabetes who required subcutaneous insulin therapy to receive either closed-loop insulin delivery (70 patients) or conventional subcutaneous insulin therapy (66).

The primary end point was the percentage of time that the sensor glucose measurement was within the target range of 100 to 180 mg per deciliter (5.6 to 10.0 mmol per liter) for up to 15 days or until hospital discharge.

The results revealed that among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia.

Read more here:
M●●●●n L●●●●●i and 3 others like this1 share